Warren Buffett's retirement marks a significant warning to investors as Berkshire Hathaway has been a net seller of stocks for 13 consecutive quarters, totaling $187 billion in sales. With the S&P 500's CAPE ratio at 39.8 in February 2026—the highest since the dot-com crash—historical data suggests the index could decline by 30% over the next three years if valuations don't improve or earnings don't grow substantially.

Billionaire Ole Andreas Halvorsen, who manages $37 billion at Viking Global Investors, recently purchased shares in two recovery story stocks: Carnival Corp., the world's largest cruise operator, and UnitedHealth Group, the top U.S. health insurer. Carnival has recovered significantly from pandemic losses and is trading at reasonable valuations with strong demand, while UnitedHealth is earlier in its turnaround journey after facing healthcare cost pressures and regulatory probes, but is taking aggressive steps to improve performance.

The global healthcare predictive analytics market is projected to grow from USD 20.57 billion in 2025 to USD 140.02 billion by 2035, with a CAGR of 21.14%. Growth is driven by increasing EHR adoption, government mandates for healthcare digitalization, value-based care adoption, and emphasis on reducing hospital readmissions. The U.S. market alone is expected to reach USD 57.64 billion by 2035. Asia Pacific is experiencing the fastest growth at 23.15% CAGR, while North America maintains the largest market share at 44.72%.

Hinge Health, a mid-cap healthcare stock focused on virtual musculoskeletal therapy, is gaining traction with insurers as a cost-reduction solution amid rising U.S. healthcare costs. The company reported 46% revenue growth and 23% EPS growth, exceeding estimates, with a study showing 56% lower spinal fusion surgery rates among its users. However, the stock faces headwinds from high stock-based compensation and projected revenue growth deceleration to 25% in 2026.

Family Insight, PC, a Whitecap Care company, announced the appointment of Kyle Williamson as Vice President of Business Development to lead expansion of its value-based care programs across multiple states. Williamson, who previously worked at Optum developing integrated behavioral health initiatives, will oversee partnerships with payers, healthcare systems, and physician practices.

UnitedHealth Group faced significant headwinds in 2025 including leadership changes, government probes, and rising healthcare costs. The company is focusing on recovery and execution in 2026. However, a new challenge emerged with the Trump administration's proposal to hold Medicare Advantage payment rates flat in 2027, which could impact profitability. Despite this, analysts note that Medicare is only part of UnitedHealth's business, and long-term prospects remain potentially bright.

Lifeward announced that Aetna has approved Medicare Advantage coverage for its ReWalk Personal Exoskeleton, joining Humana and UnitedHealthcare. The three insurers collectively represent approximately 16 million beneficiaries, significantly expanding access to the FDA-approved exoskeleton technology for individuals with spinal cord injuries.

The global clinical analytics market is experiencing rapid expansion driven by widespread EHR adoption, AI/ML advancements, and real-world evidence acceptance. The market is projected to grow at a 19.7% CAGR from $33.09 billion in 2025 to $81.32 billion by 2030, with Asia-Pacific leading regional growth. Key drivers include digital health adoption, value-based care transition, and precision medicine demand.

The article recommends three dividend stocks offering attractive yields and growth potential to compete with the 4.2% Treasury yield. UnitedHealth Group trades at a discount following earnings disappointment but maintains a safe 3.2% dividend with strong free cash flow. Ryman Hospitality Properties, a REIT owning major convention hotels and Nashville music venues, offers a 4.8% yield with solid booking growth. ONEOK, a diversified midstream energy company, provides a 5.1% yield and trades at a reasonable valuation despite recent gains.

The global ambulatory surgical center (ASC) market is projected to grow from US$ 85.9 billion in 2024 to US$ 142.6 billion by 2033, driven by cost-effectiveness, favorable reimbursement policies, expanding CMS-approved procedures, and patient preference for outpatient surgeries. Physician-owned ASCs dominate with 59.56% market share, while North America leads globally with 26.46% share. Key growth factors include significant cost savings compared to hospital outpatient departments and technological advancements enabling more complex procedures.

The article analyzes three Berkshire Hathaway holdings: DaVita and Kraft Heinz are recommended as strong buys due to positive earnings surprises and undervaluation, while UnitedHealth Group should be avoided despite recent dips, as it trades at a premium valuation with a deteriorating growth story amid lower Medicare Advantage payment increases.

CVS Health will report Q4 2025 earnings on Feb. 10, with potential guidance concerns due to lower-than-expected Medicare Advantage payment rate increases (0.9%). While CVS shares fell over 14% on this news, the company's diversified business model (retail pharmacy, PBM, insurance) may be less impacted than pure insurance competitors. Trading at under 11x forward earnings versus UnitedHealth's 16x, CVS could rally on 'better than feared' results despite near-term earnings volatility.